Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 8908
TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427512BDBM427512(US10544141, Compound 971)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427507BDBM427507(US10544141, Compound 966)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427506BDBM427506(US10544141, Compound 965)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427508BDBM427508(US10544141, Compound 967)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427504BDBM427504(US10544141, Compound 934)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427504BDBM427504(US10544141, Compound 934)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427506BDBM427506(US10544141, Compound 965)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427505BDBM427505(US10544141, Compound 964)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427529BDBM427529(US10544141, Compound 786)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427531BDBM427531(US10544141, Compound 787)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427525BDBM427525(US10544141, Compound 784)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427523BDBM427523(US10544141, Compound 693)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427527BDBM427527(US10544141, Compound 785)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427526BDBM427526(US10544141, Compound 694)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427520BDBM427520(US10544141, Compound 782)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427519BDBM427519(US10544141, Compound 642)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427522BDBM427522(US10544141, Compound 783)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427546BDBM427546(US10544141, Compound 762)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427542BDBM427542(US10544141, Compound 665)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427537BDBM427537(US10544141, Compound 790)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427536BDBM427536(US10544141, Compound 662)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427539BDBM427539(US10544141, Compound 791)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427538BDBM427538(US10544141, Compound 663)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427533BDBM427533(US10544141, Compound 788)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427535BDBM427535(US10544141, Compound 789)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427562BDBM427562(US10544141, Compound 668)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427561BDBM427561(US10544141, Compound 666)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427558BDBM427558(US10544141, Compound 765)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427557BDBM427557(US10544141, Compound 758)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427560BDBM427560(US10544141, Compound 667)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427548BDBM427548(US10544141, Compound 763)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427547BDBM427547(US10544141, Compound 744)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427550BDBM427550(US10544141, Compound 764)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427549BDBM427549(US10544141, Compound 757)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427492BDBM427492(US10544141, Compound 338)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427495BDBM427495(US10544141, Compound 554)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427494BDBM427494(US10544141, Compound 861)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427488BDBM427488(US10544141, Compound 336)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427491BDBM427491(US10544141, Compound 548)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427490BDBM427490(US10544141, Compound 337)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427487BDBM427487(US10544141, Compound 546)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427204BDBM427204(US10544141, Compound 264)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427502BDBM427502(US10544141, Compound 932)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427502BDBM427502(US10544141, Compound 932)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427503BDBM427503(US10544141, Compound 933)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427503BDBM427503(US10544141, Compound 933)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427500BDBM427500(US10544141, Compound 930)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427500BDBM427500(US10544141, Compound 930)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427501BDBM427501(US10544141, Compound 931)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

TargetProtein P(HBV)
Novira Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 427501BDBM427501(US10544141, Compound 931)
Affinity DataEC50:  55nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/2/2020
Entry Details
US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: